Press release
Focus On Biosimilars In Parathyroid Hormone Treatments For Enhanced Patient Care Trend: A Crucial Influence on the Parathyroid Hormone Market's Transformation in 2025
Parathyroid Hormone Global Market Report 2025
In recent times, the parathyroid hormone market has experienced consistent growth. Its size is projected to increase from $2.35 billion in 2024 to $2.43 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.5%. Factors contributing to this growth during the historic period include the escalating prevalence of chronic kidney disease, an enhanced understanding of disorders related to the parathyroid hormone, an increasing need for parathyroid hormone analogs, a surge in government funding for research on parathyroid hormone, and a rise in disposable incomes.
In the coming years, the parathyroid hormone market is predicted to experience robust growth. The estimated market size will reach $3.5 billion in 2029, with a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this growth during the forecast period include the increasing geriatric demographic, the proliferation of private healthcare sectors, new indications, precision medicine, heightened awareness about bone health, and expanded healthcare access. The major trends during the forecast period are anticipated to be improvements in parathyroid hormone testing, enhanced drug delivery methods, combination therapies, the incorporation of digital health, and the implementation of sustainability and green practices.
What Factors Are Fueling Growth in the Parathyroid Hormone Market?
The escalating occurrence of osteoporosis is projected to be a catalyst for the parathyroid hormone market growth. Osteoporosis, a condition distinguished by reduced bone mass and bone tissue degradation, escalates the fracture risk. As an illustration, the International Osteoporosis Foundation reported in January 2023 that around 1.4 million Canadians, chiefly postmenopausal women and seniors, were suffering from osteoporosis. Parathyroid hormone, naturally synthesized by the body to balance calcium levels, is used to mitigate the probability of bone fracture in those with osteoporosis and is dispensed through a daily subcutaneous injection. Consequently, the amplification in osteoporosis cases is expected to fuel the expansion of the parathyroid hormone market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp
Which Leading Companies Are Shaping the Growth of the Parathyroid Hormone Market?
Major companies operating in the parathyroid hormone market include Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Wockhardt, Cipla Limited
What Are the Major Trends Shaping the Parathyroid Hormone Market?
Leading firms in the parathyroid hormone market are investing in the development of biosimilars, like PTH prodrugs, which aim to improve therapeutic alternatives. These prodrugs, inactive variants of the parathyroid, become functionally active following their administration, allowing a long-lasting release and fostering consistent results for the regulation of calcium and bone health. As an example, Ascendis Pharma A/S, a biopharmaceutical company based in Denmark, received approval from the Food & Drug Administration (FDA) for YORVIPATH (palopegteriparatide) in August 2024. YORVIPATH is the first of its kind dedicated solely to the treatment of adult hypoparathyroidism. This once-daily administered prodrug provides constant PTH exposure and is estimated to benefit around 70,000 to 90,000 patients across the United States. Ascendis Pharma offers support to patients through its Ascendis Signature Access Program (A.S.A.P). However, those using the treatment are required to frequently check their serum calcium levels for potential hypercalcemia or hypocalcemia.
What Are the Key Segments of the Parathyroid Hormone Market?
The parathyroid hormone market covered in this report is segmented -
1) By Disease Type: Hypocalcemia, Hypoparathyroidism
2) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues
3) By End-User: Hospitals, Clinics, Other End-Users
Subsegments:
1) By Hypocalcemia: Pseudohypoparathyroidism, Vitamin D Deficiency
2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism, Idiopathic Hypoparathyroidism
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report
Which Region Dominates the Parathyroid Hormone Market?
The countries covered in the parathyroid hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
What Is Covered In The Parathyroid Hormone Global Market Report?
- Market Size Analysis: Analyze the Parathyroid Hormone Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Parathyroid Hormone Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Parathyroid Hormone Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Parathyroid Hormone Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3427
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Focus On Biosimilars In Parathyroid Hormone Treatments For Enhanced Patient Care Trend: A Crucial Influence on the Parathyroid Hormone Market's Transformation in 2025 here
News-ID: 3931571 • Views: …
More Releases from The Business Research Company
Trypsin-EDTA Solution For Cell Dissociation Market Research Reveals Path To $2.0 …
The trypsin-EDTA solution for cell dissociation market is poised for remarkable expansion as advances in cell therapy and biomanufacturing continue to accelerate. With increasing demands for efficient and reliable cell processing methods, this sector is on track to experience dynamic growth over the next several years. The following overview explores the market's anticipated size, leading companies, emerging trends, and key segmentations shaping its future.
Projected Market Size and Growth Path for…
Triple Negative Breast Cancer Market Demonstrates Long-Term Growth Potential At …
An in-depth look into the triple negative breast cancer market reveals promising growth and significant advancements in treatment options. As research intensifies and new therapies emerge, this sector is poised for notable expansion and increased innovation in the coming years.
Projected Market Growth of the Triple Negative Breast Cancer Market by 2030
The market for triple negative breast cancer is anticipated to experience substantial growth, reaching a valuation of $1.48…
Treatment-Resistant Depression Market Outlook Signals Expansion To $2.59 Billion …
The treatment-resistant depression market is on track for significant expansion as new therapies and technologies emerge to address persistent challenges in managing this complex condition. With ongoing advancements in personalized medicine and digital health, this sector is expected to evolve rapidly in the coming years. Here's an in-depth look at the market size, key players, influential trends, and detailed segmentation shaping the industry's outlook.
Forecast of the Treatment-Resistant Depression Market Size…
Traumatic Brain Injuries Assessment Market Report 2026 Market Outlook Supported …
The assessment of traumatic brain injuries (TBI) is a rapidly evolving field, driven by technological advancements and a growing need for precise and timely diagnosis. As healthcare providers seek more effective tools to evaluate brain trauma, the market for TBI assessment is poised for notable expansion. Below is an in-depth look at how this market is expected to develop, the leading players involved, and the trends shaping its future.
Traumatic Brain…
More Releases for Parathyroid
Parathyroid Disorders Market Therapeutic Trends, Key Drivers, and Emerging Oppor …
The Parathyroid Disorders Market is expanding steadily as cases of hyperparathyroidism, hypoparathyroidism, and calcium-regulation disorders rise worldwide. With growing awareness, improved diagnostic techniques, and advancements in hormone replacement therapies, the market is positioned for significant growth through 2034.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51969
Understanding the Parathyroid Disorders Market
Parathyroid disorders affect the four small glands located behind the thyroid, which regulate the body's calcium, phosphorus, and vitamin D…
Parathyroid Hormone Market Overview: How Parathyroid Hormone Affects Health & Cl …
Parathyroid Hormone Market is predicted to grow at a CAGR 3.4% during the forecast period (2024-2031).
Parathyroid Hormone Market Report by DataM Intelligence delivers deep insights and analysis into the latest market trends, growth opportunities, and emerging challenges. Designed to help businesses make smarter, faster decisions, our reports combine both data-driven analysis and expert perspectives. At DataM Intelligence, we're committed to turning complex market landscapes into clear, actionable strategies so…
Focus On Biosimilars In Parathyroid Hormone Treatments For Enhanced Patient Care …
What Is the Expected Size and Growth Rate of the Parathyroid Hormone Market?
In recent times, the parathyroid hormone market has experienced consistent growth. Its size is projected to increase from $2.35 billion in 2024 to $2.43 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.5%. Factors contributing to this growth during the historic period include the escalating prevalence of chronic kidney disease, an enhanced understanding of disorders…
Anti-parathyroid Agents Market - Harmony Within Reach: Anti-parathyroid Agents D …
Newark, New Castle, USA: The "Anti-parathyroid Agents Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Anti-parathyroid Agents Market: https://www.growthplusreports.com/report/antiparathyroid-agents-market/8935
This latest report researches the industry structure, sales, revenue,…
Parathyroid Hormone Analog Market to Witness Astonishing Growth by 2028
Parathyroid Hormone Analog Market is expected to witness moderate growth registering 6.4% CAGR during the forecast period (2022-2028)
Parathyroid Hormone Analog Market experts make qualitative evaluations and take important inputs from key participants to form this Parathyroid Hormone Analog Market research report. It further aims at covering significant trends and parent market trends. Market share for each industry and market capacity is covered in this Parathyroid Hormone Analog Market study report.…
Parathyroid Hormone Market to see Rapid Growth by 2028
Parathyroid Hormone Analog Market is expected to witness moderate growth registering 6.4% CAGR during the forecast period (2022-2028)
Parathyroid Hormone Market experts make qualitative evaluations and take important inputs from key participants to form this Parathyroid Hormone Market research report. It further aims at covering significant trends and parent market trends. Market share for each industry and market capacity is covered in this Parathyroid Hormone Market study report. Competitive strategies…
